SCHEMBL30689351

SCHEMBL30689351

C=C(Cc1nc(-c2ccc(Oc3ccc(C(F)(F)F)nn3)cc2)no1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.41
▸ GSTP1 P09211 4/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC2 Q92769 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ TP53 P04637 3/20 0.39
▸ MITF O75030 1/20 0.39
▸ NCOA3 Q9Y6Q9 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ PKM P14618 1/20 0.38
▸ XBP1 P17861 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ACACB O00763 1/20 0.38
▸ MMP2 P08253 1/20 0.37
▸ MMP9 P14780 1/20 0.37
▸ MMP14 P50281 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30689328 0.85 FFAR1 (0.43) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL30689340 0.85 GSTP1 (0.41) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL30689366 0.85 SCN9A (0.44) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL30689302 0.83 FFAR1 (0.49) FFAR1GSTP1LMNATP53MAPT
SCHEMBL30689333 0.82 GSTP1 (0.43) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL31527959 0.81 LMNA (0.42) FFAR1GSTP1LMNAATMTP53
SCHEMBL30689345 0.80 FFAR1 (0.45) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL30689419 0.80 FFAR1 (0.53) FFAR1GSTP1LMNAATMHDAC1
SCHEMBL30689438 0.78 LMNA (0.51) GSTP1LMNAATMHDAC1HDAC2
SCHEMBL31527955 0.78 LMNA (0.46) LMNAATMTP53MITFNCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543875-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES Sitryx Therapeutics Limited (GB) 2025-04-30 — — EP disclosed
WO-2023247958-A1 OXADIAZOLE DERIVATIVES, PREPARATION PROCESS THEREOF AND THEIR USE IN TREATING INFLAMMATORY DISEASES SITRYX THERAPEUTICS LIMITED (GB) 2023-12-28 — — WO disclosed
Send feedback